These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 15810123)

  • 1. Bibliography. Current world literature. Cancer biology.
    Curr Opin Oncol; 2005 Jan; 17(1):67-82. PubMed ID: 15810123
    [No Abstract]   [Full Text] [Related]  

  • 2. Bibliography. Current world literature. Cancer biology.
    Curr Opin Oncol; 2001 Jan; 13(1):B25-39. PubMed ID: 11196245
    [No Abstract]   [Full Text] [Related]  

  • 3. Excavating relics of DNA methylation changes during the development of neoplasia.
    Hsiao SH; Huang TH; Leu YW
    Semin Cancer Biol; 2009 Jun; 19(3):198-208. PubMed ID: 19429484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cancer genetics. A review of oncological molecular biology seen in relation to the human genome].
    Gerdes AM
    Ugeskr Laeger; 2002 May; 164(22):2865-71. PubMed ID: 12082811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dominant-negative histone H3 lysine 27 mutant derepresses silenced tumor suppressor genes and reverses the drug-resistant phenotype in cancer cells.
    Abbosh PH; Montgomery JS; Starkey JA; Novotny M; Zuhowski EG; Egorin MJ; Moseman AP; Golas A; Brannon KM; Balch C; Huang TH; Nephew KP
    Cancer Res; 2006 Jun; 66(11):5582-91. PubMed ID: 16740693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oncogene and tumor suppressor gene].
    Watanabe N
    Rinsho Byori; 2002 Nov; Suppl 123():131-6. PubMed ID: 12652800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epigenetics: significance for tumor genesis and clinical features].
    Arnold C; Usadel H; Blum HE
    Dtsch Med Wochenschr; 2002 Aug; 127(33):1701-3. PubMed ID: 12183803
    [No Abstract]   [Full Text] [Related]  

  • 9. Genome-wide combination profiling of copy number and methylation offers an approach for deciphering misregulation and development in cancer cells.
    Park JJ; Kang JK; Hong S; Ryu ES; Kim JI; Lee JH; Seo JS
    Gene; 2008 Jan; 407(1-2):139-47. PubMed ID: 17997235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cell and disease. X. disorders in signal transduction: dysregulation of cell growth in cancer].
    Zwarthoff EC
    Ned Tijdschr Geneeskd; 1993 Nov; 137(45):2310-4. PubMed ID: 8255337
    [No Abstract]   [Full Text] [Related]  

  • 11. New insights on oxidative stress in cancer.
    Visconti R; Grieco D
    Curr Opin Drug Discov Devel; 2009 Mar; 12(2):240-5. PubMed ID: 19333869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A SLAMS dunk for cancer regulators.
    Kumar-Sinha C; Chinnaiyan AM
    Nat Biotechnol; 2006 May; 24(5):524-6. PubMed ID: 16680134
    [No Abstract]   [Full Text] [Related]  

  • 13. DNA methylation and sensitivity to antimetabolites in cancer cell lines.
    Sasaki S; Kobunai T; Kitayama J; Nagawa H
    Oncol Rep; 2008 Feb; 19(2):407-12. PubMed ID: 18202788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bibliography. Current World Literature. Cancer biology.
    Curr Opin Oncol; 2000 Jan; 12(1):B18-41. PubMed ID: 10687739
    [No Abstract]   [Full Text] [Related]  

  • 15. X-chromosome genetics and human cancer.
    Spatz A; Borg C; Feunteun J
    Nat Rev Cancer; 2004 Aug; 4(8):617-29. PubMed ID: 15286741
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cancer initiation as mini-evolution].
    Iwasa Y
    Tanpakushitsu Kakusan Koso; 2005 Dec; 50(15):1962-9. PubMed ID: 16363646
    [No Abstract]   [Full Text] [Related]  

  • 17. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
    Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
    J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The same gene can be tumour suppressing and tumour promoting.
    Bains W
    Med Hypotheses; 2008; 70(5):1066. PubMed ID: 18180111
    [No Abstract]   [Full Text] [Related]  

  • 19. Individualized cancer therapy: molecular approaches to the prediction of tumor response.
    McLeod HL
    Expert Rev Anticancer Ther; 2002 Feb; 2(1):113-9. PubMed ID: 12113060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Momentum building for human epigenome project.
    Garber K
    J Natl Cancer Inst; 2006 Jan; 98(2):84-6. PubMed ID: 16418505
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.